| 1901745 | Glycaemic Index Dietary Education for glucose abnormalities in CF | 30/06/2020 |
| 1812724 | Investigating inhaled Promixin in the treatment of non-cystic fibrosis bronchiectasis | 01/04/2019 |
| 1811716 | PTI-808-01 | 30/06/2019 |
| 1811706 | VX17-445-103 Efficacy and Safety of VX-445/TEZ/IVA in CF Homozygous | 31/01/2019 |
| 1811705 | VX17-445-102 Efficacy and Safety of VX-445/TEZ/IVA in CF Het-min | 30/06/2019 |
| 1810684 | INTREPID: INvestigation of TRELEGY Effectiveness: Usual PractIce | 10/12/2019 |
| 1804573 | TRAIL1 | 31/10/2019 |
| 1802593 | HOPE-1 | 07/01/2019 |
| 1801561 | Living with Cystic Fibrosis (v2) | 01/09/2019 |
| 1801558 | MA39189 | 14/04/2019 |
| 1711532 | ACtiF – RCT and parallel process evaluation (WP 3.2 and 3.3) | 31/12/2019 |
| 1710516 | Idiopathic Pulmonary Fibrosis Job Exposures Study (IPF JES) | 01/10/2019 |
| 1708473 | RESP 5165 | 30/10/2021 |
| 1611335 | Rituximab versus cyclophosphamide in connective tissue disease-ILD (RECITAL) | 31/08/2019 |
| 1608290 | EMBARC: European Bronchiectasis Registry | 04/01/2021 |
| 1605253 | VX14-661-110 Cystic Fibrosis | 31/03/2020 |
| 1510142 | Treating pulmonary fibrosis with cotrimoxazole | 31/07/2019 |
| 1507118 | Adjuvant Steroids in Adults with Pandemic Influenza | 01/05/2025 |
| 1507115 | ILD Genetics – Identification of disease susceptibility genes and autoantibodies associated with the development and clinical characteristics of interstitial lung disease (ILD) in patients with and without proven connective tissue diseases (CTDs). | 01/03/2021 |
